Jiangsu Aidea Pharmaceutical Co Ltd - Class A

SHSE:688488 (China)   Class A
Â¥ 15.63 (-2.01%) May 15
At Loss
P/B:
5.90
Market Cap:
Â¥ 6.58B ($ 910.71M)
Enterprise V:
Â¥ 6.76B ($ 936.29M)
Volume:
283.65M
Avg Vol (2M):
4.56M
Volume:
283.65M
At Loss

Business Description

Description
Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.
Name Current Vs Industry Vs History
Cash-To-Debt 0.89
Equity-to-Asset 0.64
Debt-to-Equity 0.41
Debt-to-EBITDA -4.73
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.29
Distress
Grey
Safe
Beneish M-Score -2.15
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 10.2
3-Year Book Growth Rate -6.2
Name Current Vs Industry Vs History
5-Day RSI 47.51
9-Day RSI 51.51
14-Day RSI 52.65
6-1 Month Momentum % 22.24
12-1 Month Momentum % 31.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.54
Quick Ratio 1.2
Cash Ratio 0.71
Days Inventory 310.37
Days Sales Outstanding 178.25
Days Payable 198.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1
Shareholder Yield % -3.34
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Jiangsu Aidea Pharmaceutical Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 391.637
EPS (TTM) (Â¥) -0.211
Beta 1.2
Volatility % 46.62
14-Day RSI 52.65
14-Day ATR (Â¥) 0.895211
20-Day SMA (Â¥) 15.5095
12-1 Month Momentum % 31.06
52-Week Range (Â¥) 9.63 - 17.4
Shares Outstanding (Mil) 420.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Jiangsu Aidea Pharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Jiangsu Aidea Pharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Jiangsu Aidea Pharmaceutical Co Ltd Frequently Asked Questions

What is Jiangsu Aidea Pharmaceutical Co Ltd(SHSE:688488)'s stock price today?
The current price of SHSE:688488 is ¥15.63. The 52 week high of SHSE:688488 is ¥17.40 and 52 week low is ¥9.63.
When is next earnings date of Jiangsu Aidea Pharmaceutical Co Ltd(SHSE:688488)?
The next earnings date of Jiangsu Aidea Pharmaceutical Co Ltd(SHSE:688488) is .
Does Jiangsu Aidea Pharmaceutical Co Ltd(SHSE:688488) pay dividends? If so, how much?
Jiangsu Aidea Pharmaceutical Co Ltd(SHSE:688488) does not pay dividend.

Press Release

Subject Date
No Press Release